ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
AzurRx BioPharma Inc

AzurRx BioPharma Inc (AZRX)

3.45
0.00
(0.00%)
종가: 07 1월 6:00AM
3.45
0.00
( 0.00% )
시간외 거래: -

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

주요 통계 및 세부정보

가격
3.45
매수가
3.41
매도가
3.51
거래량
-
0.00 일간 변동폭 0.00
0.00 52주 범위 0.00
market_cap
전일 종가
3.45
개장가
-
최근 거래 시간
마지막 거래 시간
-
재정 규모
-
VWAP
-
평균 볼륨(3m)
-
발행 주식
13,500,000
배당수익률
-
주가수익률
-2.48
주당순이익(EPS)
-1.19
매출
-
순이익
-16.1M

AzurRx BioPharma Inc 정보

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
본부
Dover, Delaware, USA
설립됨
-

AZRX 최신 뉴스

AzurRx BioPharma to Change Corporate Name to First Wave BioPharma Today

BOCA RATON, Fla., Sept. 21, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX) (“First Wave” or the “Company”), a clinical-stage biopharmaceutical company specializing in the...

AzurRx BioPharma CEO Issues Letter to Shareholders Regarding Recent Acquisition of First Wave Bio and Creation of First Wave BioPharma

BOCA RATON, Fla., Sept. 14, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in...

AzurRx BioPharma Announces Acquisition of First Wave Bio and its Proprietary Niclosamide Formulations Targeting Multi-Billion Dollar Inflammatory Bowel Disease Indications

AzurRx BioPharma to be renamed “First Wave BioPharma” and trade under new NASDAQ ticker symbol, “FWBI” Three IBD clinical indications, including ulcerative colitis and Crohn’s disease, added to...

AzurRx BioPharma Announces Reverse Stock Split

BOCA RATON, Fla., Sept. 10, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a clinical stage biopharmaceutical company specializing in the...

AzurRx BioPharma Activates New Clinical Trial Sites in India for Phase 2 RESERVOIR Trial Evaluating Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections

BOCA RATON, Fla., Sept. 10, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company specializing in the development of targeted non-systemic...

AzurRx BioPharma Announces Positive Results from Independent Data Monitoring Committee Review of Safety Data from Part 1 of RESERVOIR Phase 2 Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections

Review of Interim Safety Data Concluded with Favorable Recommendation to Continue RESERVOIR Trial as Planned Part 2 of RESERVOIR Trial to Enroll Up to 150 Patients to Evaluate Efficacy of FW-1022...

AzurRx BioPharma to Present at the Virtual H.C. Wainwright 23rd Annual Global Investment Conference

BOCA RATON, Fla., Sept. 07, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company specializing in the development of targeted...

AzurRx BioPharma Announces Positive Topline Data For Phase 2 MS1819 Combination Therapy Trial in Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency (EPI)

MS1819 and PERT combination therapy achieves primary and secondary outcome measure endpointsStudy data indicates clinically meaningful improvement in coefficient of fat absorption (CFA) primary...

AzurRx BioPharma Announces WHO Publication of “Adrulipase Alfa” as International Nonproprietary Name for MS1819

BOCA RATON, Fla., Aug. 17, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company specializing in the development of targeted...

AzurRx BioPharma Announces Appointment of Terry Coelho to its Board of Directors

BOCA RATON, Fla., Aug. 16, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company specializing in the development of targeted non-systemic...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

AZRX - Frequently Asked Questions (FAQ)

What is the current AzurRx BioPharma share price?
The current share price of AzurRx BioPharma is US$ 3.45
How many AzurRx BioPharma shares are in issue?
AzurRx BioPharma has 13,500,000 shares in issue
What is the market cap of AzurRx BioPharma?
The market capitalisation of AzurRx BioPharma is USD 46.58M
What is the 1 year trading range for AzurRx BioPharma share price?
AzurRx BioPharma has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the PE ratio of AzurRx BioPharma?
The price to earnings ratio of AzurRx BioPharma is -2.48
What is the reporting currency for AzurRx BioPharma?
AzurRx BioPharma reports financial results in USD
What is the latest annual profit for AzurRx BioPharma?
The latest annual profit of AzurRx BioPharma is USD -16.1M
What is the registered address of AzurRx BioPharma?
The registered address for AzurRx BioPharma is 850 NEW BURTON ROAD, SUITE 201, KENT, DOVER, DELAWARE, 19904
What is the AzurRx BioPharma website address?
The website address for AzurRx BioPharma is www.enterothera.com
Which industry sector does AzurRx BioPharma operate in?
AzurRx BioPharma operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
MSAIMultiSensor AI Holdings Inc
US$ 2.80
(40.00%)
2.52M
MCVTMill City Ventures III Ltd
US$ 3.10
(37.17%)
85.45k
XTIAXTI Aerospace Inc
US$ 0.1115
(26.70%)
362.56M
QRTEBQurate Retail Inc
US$ 3.13
(22.27%)
103
NARIInari Medical Inc
US$ 78.80
(21.23%)
4.7M
AMSTAmesite Inc
US$ 3.38
(-16.54%)
59.87k
GDTCCytoMed Therapeutics Ltd
US$ 2.89
(-15.74%)
61.92k
ENVBEnveric Biosciences Inc
US$ 0.3568
(-15.55%)
377.21k
ACXPAcurx Pharmaceuticals Inc
US$ 0.924
(-15.23%)
165.97k
SLRNACELYRIN Inc
US$ 2.98
(-14.61%)
505.98k
XTIAXTI Aerospace Inc
US$ 0.1115
(26.70%)
362.56M
SVMHSRIVARU Holding Ltd
US$ 0.0519
(12.10%)
29.45M
CRKNCrown Electrokinetics Corporation
US$ 0.1401
(5.34%)
25.17M
CEROCERo Therapeutics Holdings Inc
US$ 0.0489
(15.60%)
17.02M
CDTConduit Pharmaceuticals Inc
US$ 0.0827
(14.38%)
16.62M
cottonmather cottonmather 4 분 전
Tidbits: USS Harry Truman experienced a largescale attack of drones and missiles. No direct hits. Trump continues backing off his promises - tarrifs falling to the side.
freecs freecs 5 분 전
Lol yikes. Speechifying.
RDAR
Pickme2 Pickme2 6 분 전
Ok Ones...another foolish remark as always
ATMH
cottonmather cottonmather 6 분 전
Tidbits: USS Harry Truman experienced a largescale attack of drones and missiles. No direct hits. Trump continues backing off his promises - tarrifs falling to the side.
Jimmy Joe Jimmy Joe 6 분 전
It's all relative.
DBMM
janice shell janice shell 7 분 전
What on earth are "real nobel prize clinical trials with the fda"???
bbotcs bbotcs 8 분 전
al44: That article was made to order for you!
SSKILLZ1 SSKILLZ1 8 분 전
SSKMP Managed Index (As Of 1/6/25)

Daily Performance
-0.45%

YTD Performance
+0.10%

Overall Performance
+519.55% (Including Options Trading +383.53%)
Tony53711 Tony53711 8 분 전
Zivo blew opportunities during the pandemic to find a partner with funding to quickly develop a therapeutic. Didn’t they learn their lesson? We were told during the last test it was funded by a partner and agreements would be signed pending results. Results were positive and we are going on how many
ZIVO
Techroemancer Techroemancer 8 분 전
Just for the fun of it, why not?

If we have major news and updates - .15+
If we have lots of news but nothing major - .07
If we have a little news but nothing major - .03
If we have no news - .008

All guessing here
MGON
Jimmy Joe Jimmy Joe 9 분 전
Looks like a big block position is being sold.

Total NONSENSE. What big block you are talking about~?
Only 459K total volume dude.
Big sells would be 100 million total volume.
Big covering would be 100s of millions or billions of shares in a single day.
DBMM
4C 4C 11 분 전
Has JHB laid down the law to Dalton?

We know Dalton's wife has been unwell, and there were rumors on LinkedIn that he himself might have some kind of health issue, we also know they've relocated to Georgia and it's highly likely that they have moved in with Chiatra and JHB.
UNVC
WojD40 WojD40 11 분 전
But aren’t we thinking that a majority of the remaining short position is being held by people who also have warrants? I’m a little confused by this. Why wouldn’t you cover at sub $0.30 when you sold short at $0.75-$1.00.
NWBO
TOM611 TOM611 11 분 전
Lets. Go. Xall. I added. 2 milly. More today.  
XALL
GREGG THE GREEK GREGG THE GREEK 11 분 전
Beauty move to .17 high earlier in AH trading and holding up nicely here .147 area.


RIME
RIME
Mr. Dragon Mr. Dragon 11 분 전
$489 traded today🤣🤣🤣....yup....the scam is now very well known.
VPER
x993231 x993231 11 분 전
If only you had a pair of polarized sun glasses, truer words have never been spoken.

Good luck.

X
LWLG
wiwineguy wiwineguy 11 분 전
One less Pappy to buy.  Be wasted on C anyway.
TGLO
ThunderousSeer8 ThunderousSeer8 11 분 전
He can't even understand the meaning of the reply 😂😂😂

Absolutely. I go to work in a very secure career I've had for almost nine years. I make good money and can afford to risk some for more than flips and I'm not tempted to dump my shares either. It affords sec
RDAR
mick mick 13 분 전
IS THAT 6 BID
IHGP
mick mick 13 분 전
IS THAT 6 BID
IHGP
Hoskuld Hoskuld 13 분 전
If they needed a 2nd trial then they would have been discouraged from applying and their MAA would not have been accepted.
AVXL
vlispxpert vlispxpert 13 분 전
GCTK .37 insider stake filing on Friday, then they do an offering:

https://www.gurufocus.com/news/2645624/sabby-management-llc-acquires-significant-stake-in-glucotrack-inc?r=4bf001661e6fdd88d0cd7a5659ff9748

strange they'd do that to their biggest holder, unless Sabby b
GCTK
The Great Pumpkin The Great Pumpkin 14 분 전
Not from the diagrams. eom

#scam
LWLG
nunaka nunaka 14 분 전
Why don't you just repost that information from a credible source if it is, infact, a fact?
RDGL

최근 히스토리

Delayed Upgrade Clock